Heart disease and dementia: A population-based study

American Journal of Epidemiology

Volumn 163, Issue 2, 2006, Pages 135-141

  Bursi, Francesca ^a   Rocca, Walter A ^a   Killian, Jill M ^a   Weston, Susan A ^a   Knopman, David S ^a   Jacobsen, Steven J ^a   Roger, Véronique L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Case control studies; Cohort studies; Death; Dementia; Myocardial infarction; Odds ratio; Survival analysis

Indexed keywords

MENTAL HEALTH;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMENTIA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HEART DEATH; HEART DISEASE; HEART INFARCTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MINNESOTA; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 30344455012     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj025     Document Type: Article

References (51)

1. Roger VL, Jacobsen SJ, Weston SA, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med 2002;136:341-8.
2. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337-42.
3. von Strauss E, Viitanen M, De Ronchi D, et al. Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol 1999;56:587-92.
4. Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 2004;363:1139-46.
5. Ott A, Andersen K, Dewey ME, et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology 2004;62:920-4.
6. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-51.
7. de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002;33:1152-62.
8. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-4.
9. Langa KM, Foster NL, Larson EB. Mixed dementia: emerging concepts and therapeutic implications. JAMA 2004;292:2901-8.
10. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 2004;5:347-60.
11. Zuccala G, Onder G, Pedone C, et al. Hypotension and cognitive impairment: selective association in patients with heart failure. Neurology 2001;57:1986-92.
12. Grubb NR, Simpson C, Fox KA. Memory function in patients with stable, moderate to severe cardiac failure. Am Heart J 2000;140:1-5.
13. Breteler MM, Claus JJ, Grobbee DE, et al. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ 1994;308:1604-8.
14. Aronson MK, Ooi WL, Morgenstern H, et al. Women, myocardial infarction, and dementia in the very old. Neurology 1990;40:1102-6.
15. Petrovitch H, White L, Masaki KH, et al. Influence of myocardial infarction, coronary artery bypass surgery, and stroke on cognitive impairment in late life. Am J Cardiol 1998;81:1017-21.
16. Melton LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-74.
17. H-ICDA, hospital adaptation of ICDA. 2nd ed. Ann Arbor, MI: Commission on Professional and Hospital Activities, 1973.
18. Kokmen E, Beard CM, O'Brien PC, et al. Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984). Neurology 1993;43:1887-92.
19. Rocca WA, Cha RH, Waring SC, et al. Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. Am J Epidemiol 1998;148:51-62.
20. Knopman DS, Rocca WA, Cha RH, et al. Incidence of vascular dementia in Rochester, Minn, 1985-1989. Arch Neurol 2002;59:1605-10.
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-FV. 4th ed. Washington, DC: American Psychiatric Association, 1994.
22. White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 1996;49:223-33.
23. Roger VL, Killian J, Henkel M, et al. Coronary disease surveillance in Olmsted County objectives and methodology. J Clin Epidemiol 2002;55:593-601.
24. Centers for Medicare and Medicaid Services. International classification of diseases. Ninth Revision, clinical modification. Washington, DC: Department of Health and Human Services, 2002.
25. Prineas R, Crow R, Blackburn H. The Minnesota Code manual of electrocardiographic findings. Littleton, MA: John Wright-PSG, Inc, 1982.
26. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-50.
27. Smith Sehdev AE, Hutchins GM. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med 2001;161:277-84.
28. Kelsey JL, Thompson WD, Evans AS. Methods in observational epidemiology. New York, NY: Oxford University Press, 1986.
29. Keene J, Hope T, Fairburn CG, et al. Death and dementia. Int J Geriatr Psychiatry 2001;16:969-74.
30. World Health Organization. International statistical classification of diseases and related health problems. 10th Revision. Geneva, Switzerland: World Health Organization, 2003.
31. Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695-706.
32. Satagopan JM, Ben-Porat L, Berwick M, et al. A note on competing risks in survival data analysis. Br J Cancer 2004;91:1229-35.
33. Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 2002;137:149-55.
34. Wilson PW, Schaefer EJ, Larson MG, et al. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-5.
35. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
36. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
37. Schmidt R, Schmidt H, Curb JD, et al. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002;52:168-74.
38. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421.
39. Yaffe K, Lindquist K, Penninx BW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003;61:76-80.
40. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-56.
41. Slooter AJ, Cruts M, Ott A, et al. The effect of APOE on dementia is not through atherosclerosis: the Rotterdam Study. Neurology 1999;53:1593-5.
42. Knopman DS, Petersen RC, Cha RH, et al. Coronary artery bypass grafting is not a risk factor for dementia or Alzheimer disease. Neurology 2005;65:986-90.
43. Elbaz A, Peterson BJ, Bower JH, et al. Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study. Mov Disord 2005;20:719-25.
44. Dewey ME, Saz P. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry 2001;16:751-61.
45. Jagger C, Clarke M, Stone A. Predictors of survival with Alzheimer's disease: a community-based study. Psychol Med 1995;25:171-7.
46. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
47. Lanska DJ. Dementia mortality in the United States. Results of the 1986 National Mortality Followback Survey. Neurology 1998;50:362-7.
48. Foley DJ, Brock DB, Lanska DJ. Trends in dementia mortality from two National Mortality Followback Surveys. Neurology 2003;60:709-11.
49. Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA 2004;291:88-93.
50. Will JC, Vinicor F, Stevenson J. Recording of diabetes on death certificates. Has it improved? J Clin Epidemiol 2001;54:239-44.
51. Malarcher AM, Schulman J, Epstein LA, et al. Methodological issues in estimating smoking-attributable mortality in the United States. Am J Epidemiol 2000;152:573-84.